EPKINLY™ (ep-KIN-lee) (epcoritamab-bysp) injection, for subcutaneous use

Genmab US, Inc.

EPKINLY is a prescription medicine used to treat adults with certain types of diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma that has come back (relapsed) or that did not respond to previous treatment (refractory), and who have already received 2 or more treatments for their cancer. It is not known if EPKINLY is safe and effective in children.